Adverse effects observed in trials to date include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation (common with GLP-1 receptor agonists) Reduced appetite and weight loss , which may be excessive in some individuals Elevated heart rate , a concern noted with glucagon receptor agonism As with other incretin-based therapies, there is also a class-level signal for acute pancreatitis and gallbladder disease (including cholelithiasis and cholecystitis)
Where GHRP-2 offers potency at the cost of a broader hormonal footprint, ipamorelin trades a slice of the ghrelin-like breadth for a cleaner, GH-focused signal
Low blood sugar is a key cause of dizziness, especially in people with diabetes who also use insulin or sulfonylureas, since glucose is the brains primary energy source
A 2025 narrative review published in the journal Nutrients on nutritional approaches to complement GLP-1 therapy noted that probiotic supplementation may be a promising adjunct to GLP-1 treatment, with potential benefits for both gut microbiome balance and digestive tolerability
Potential Risks and Side Effects: Like any medical intervention, lipotropic injections may come with potential risks and side effects
Q: How should BPC-157 be stored